Drug Information Analysis Service

Bauwens SF . Osteomalacia and osteoporosis. In: DiPiro JT Talbert RL Hayes PE Yee GC Posey LM , eds. Pharmacotherapy: A pathophysiologic approach. New York: Elsevier, 1989: 865–80.

Riggs BL . A new option for treating osteoporosis. N Engl J Med 1990; 323: 124–5.

Etidronate for postmenopausal osteoporosis. Med Lett Drugs Ther 1990; 32: 111–2.

Dawson-Hughes B Dallal GE Krall EA Sadowski L Sahyoun N Tannenbaum S . A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 1990; 323: 878–83.

Chapuy MC Arlot ME Duboeuf F Brun J Crouzet B Arnaud S Vitamin D₃ and calcium to prevent hip fractures in elderly women. N Engl J Med 1992; 327: 1637–42.

Stevenson JC Evans IMA . Pharmacology and therapeutic use of calcitonin. Drugs 1981; 21: 257–72.

Wallach S . Treatment of Paget's disease. Adv Intern Med 1982; 27: 1–43.

Heaney RP Saville PE . Etidronate disodium in postmenopausal osteoporosis. Clin Pharmacol Ther 1976; 20: 593–604.

Haynes RC . Agents affecting calcification: Calcium, parathyroid hormone, calcitonin, vitamin D, and other compounds. In: Gilman AG Rail TW Nies AS Taylor P , eds. Goodman and Gilman's the pharmacological basis of therapeutics. New York: Pergamon Press, 1990: 1509–10.

Storm T Thamsborg G Steiniche T Genant HK Sorensen OH . Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 1990; 322: 1265–71.

Watts NB Harris ST Genant HK Wasnich RD Miller PD Jackson RD Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 1990; 323: 73–9.

Forys VA . Etidronate and osteoarthritis (letter). JAMA 1991: 265: 2807.

Didronel PMO 50% fracture rate increase in follow-up study concerns FDA advisory committee; panel splits on approval vote, more data is needed. FDC Rep 1991; 53 (10):3–4.

Jones PBB McCloskey EV Kanis JA . Transient taste-loss during treatment with etidronate (letter). Lancet 1987; 2: 637.

Doucette MM Fylling CP Knighton DR . Amputation prevention in a high-risk population through comprehensive wound-healing protocol. Arch Phys Med Rehabil 1989; 70: 780–5.

Fylling CP . Comprehensive wound management with topical growth factors. Ostomy/Wound Manage 1989; 22: 62–71.

Longe RL . Current concepts in clinical therapeutics: Pressure sores. Clin Pharm 1986; 5: 669–81.

Arnold F West DC . Angiogenesis in wound healing. Pharmacol Ther 1991; 52: 407–22.

Knighton DR Hunt TK Thakral KK Goodson WH . Role of platelets and fibrin in the healing sequence. An in vivo study of angiogenesis and collagen synthesis. Ann Surg 1982; 196: 379–87.

Cromack DT Porras-Reyes B Mustoe TA . Current concepts in wound healing. Growth factor and macrophage interaction. J Trauma 1990; 30 (suppl):S129–32.

Knighton DR Fiegel VD Austin LL Ciresi KF Butler EL . Classification and treatment of chronic non-healing wounds. Successful treatment with autologous platelet-derived wound healing factors. Ann Surg 1986; 204: 322–30.

Hunt TK . Basic principles of wound healing. J Trauma 1990; 30 (suppl):S122–8.

Knighton DR Ciresi K Fiegel VD Schumert S Butler EL Cerra F . Stimulation of repair in chronic, non-healing, cutaneous ulcers using platelet-derived wound healing formula. Surg Gynecol Obstet 1990; 170: 56–60.

Ross R . Platelet-derived growth factor. Lancet 1989; 1: 1179–82.

Knighton DR Fylling CP Fiegel VD Cerra F . Amputation prevention in an independently reviewed at-risk diabetic population using a comprehensive wound care protocol. J Surg 1990; 160: 466–72.

Atri SC Mirsa J Bisht D Mirsa K . Use of homologous platelet factors in achieving total healing of recalcitrant skin ulcers. Surgery 1990; 108: 508–12.

Fylling CP McKeown PC . Cost and healing efficacy of treating diabetic foot ulcers in a comprehensive wound management program with growth factor therapy (abstract). Diabetes 1990; 39 (suppl):18A.

Robinson JH . Healing chronic wounds with epidermal growth factor (letter). Plast Reconstr Surg 1992; 89: 771.

Bennett AH Carpenter AJ Barada JH . An improved vasoactive drug combination for a pharmacological erection program. J Urol 1991; 146: 1564–5.

Floth A Schramek P . Intracavemous injection of prostaglandin E1 in combination with papaverine: Enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone. J Urol 1991; 145: 56–9.

Mudd JW . Impotence responsive to glyceryl trinitrate. Am J Psychiatry 1977; 134: 922–5.

Talley JD Crawley IS . Transdermal nitrate, penile erection, and spousal headache (letter). Ann Intern Med 1985; 103: 804.

Ahmad S . Scleroderma and impotence: Response to nitroglycerin applied to the fingers and penis (letter). South Med J 1990; 83: 1495.

Negelev S . Re: Topical nitroglycerin: A potential treatment for impotence (letter). J Urol 1990; 143: 586.

Godec CJ Narkhede N Tomasula JJ . The use of nitroglycerin in impotent patients (abstract). J Urol 1987; 137: 184A.

Nuñez BD Anderson DC . Nitroglycerin ointment in the treatment of impotence. J Urol (in press).

Heaton JP Morales A Owen J Saunders FYV Fenemore J . Topical glyceryl trinitrate causes measurable penile arterial dilation in impotent men. J Urol 1990; 143: 729–31.

Barbanti G Beneforti P Lapini A Turini D . Relaxation of isolated corpus cavemosum induced by smooth-muscle relaxant drugs. A comparative study. Urol Res 1988; 16: 299–302.

Heaton JP . Synthetic nitrovasodilators are effective, in vitro, in relaxing penile tissue from impotent men: The findings and their implications. Can J Physiol Pharmacol 1989; 67: 78–81.

Owen JA Saunders F Harris C Fenemore J Reid K Surridge DH Topical nitroglycerin: A potential treatment for impotence. J Urol 1989; 141: 546–8.

Cavallini G . Minoxidil versus nitroglycerin: A prospective double-blind controlled trial in transcutaneous erection facilitation for organic impotence. J Urol 1991; 146: 50–3.

Meyhoff HH Rosenkiide P Bodker A . Non-invasive management of impotence with transcutaneous nitroglycerin. Br J Urol 1992; 69: 88–90.

Sonksen J Biering-Sorensen F . Transcutaneous nitroglycerin in the treatment of erectile dysfunction in spinal cord injured. Paraplegia 1992; 30: 554–7.

Claes H Baert L . Transcutaneous nitroglycerin therapy in the treatment of impotence. Urol Int 1989; 44: 309–12.

Morales A Condra M Owen JE Fenemore J Surridge DH . Oral and transcutaneous pharmacologic agents in the treatment of impotence. Urol Clin North Am 1988; 15: 87–93.